Brunasso Lara, Bonosi Lapo, Costanzo Roberta, Buscemi Felice, Giammalva Giuseppe Roberto, Ferini Gianluca, Valenti Vito, Viola Anna, Umana Giuseppe Emmanuele, Gerardi Rosa Maria, Sturiale Carmelo Lucio, Albanese Alessio, Iacopino Domenico Gerardo, Maugeri Rosario
Neurosurgical Clinic AOUP "Paolo Giaccone", Post Graduate Residency Program in Neurologic Surgery, Department of Biomedicine Neurosciences and Advanced Diagnostics, School of Medicine, University of Palermo, 90127 Palermo, Italy.
Department of Radiation Oncology, REM Radioterapia SRL, 95125 Catania, Italy.
Cancers (Basel). 2022 Aug 27;14(17):4163. doi: 10.3390/cancers14174163.
Several recent studies are providing increasing insights into reliable markers to improve the diagnostic and prognostic assessment of meningioma patients. The evidence of brain invasion (BI) signs and its associated variables has been focused on, and currently, scientific research is investing in the study of key aspects, different methods, and approaches to recognize and evaluate BI. This paradigm shift may have significant repercussions for the diagnostic, prognostic, and therapeutic approach to higher-grade meningioma, as long as the evidence of BI may influence patients' prognosis and inclusion in clinical trials and indirectly impact adjuvant therapy. We intended to review the current knowledge about the impact of BI in meningioma in the most updated literature and explore the most recent implications on both clinical practice and trials and future directions. According to the PRISMA guidelines, systematic research in the most updated platform was performed in order to provide a complete overview of characteristics, preoperative applications, and potential implications of BI in meningiomas. Nineteen articles were included in the present paper and analyzed according to specific research areas. The detection of brain invasion could represent a crucial factor in meningioma patients' management, and research is flourishing and promising.
最近的几项研究正在为改善脑膜瘤患者的诊断和预后评估提供越来越多关于可靠标志物的见解。脑侵袭(BI)体征及其相关变量的证据受到了关注,目前,科学研究正在投入到识别和评估BI的关键方面、不同方法和途径的研究中。只要BI的证据可能影响患者的预后、纳入临床试验情况并间接影响辅助治疗,这种范式转变可能会对高级别脑膜瘤的诊断、预后和治疗方法产生重大影响。我们旨在回顾最新文献中关于BI对脑膜瘤影响的当前知识,并探讨其对临床实践、试验以及未来方向的最新影响。根据PRISMA指南,在最新平台上进行了系统研究,以全面概述BI在脑膜瘤中的特征、术前应用及潜在影响。本文纳入了19篇文章,并根据特定研究领域进行了分析。脑侵袭的检测可能是脑膜瘤患者管理中的一个关键因素,相关研究正在蓬勃发展且前景广阔。